VS ??? ?? - PowerPoint PPT Presentation

About This Presentation
Title:

VS ??? ??

Description:

CAPD guide line VS CAPD CR KT/V – PowerPoint PPT presentation

Number of Views:60
Avg rating:3.0/5.0
Slides: 50
Provided by: tnsg
Category:
Tags: hbsag | test

less

Transcript and Presenter's Notes

Title: VS ??? ??


1
CAPD guide line
  • VS ??? ??
  • CAPD??
  • CR ??? ??

2
??? ????
  • ?? KT/V lt 2
  • GFR lt10.5/min/1.73m2


  • DOQUI guideline 2

3
Before peritoneal dialysis
  • 1. PD start 10 days to 2 weeks
  • after catheter placement.
  • 2. If PD started in lt 10 days
  • following catheter placement,
  • ?do low-volume, supine dialysis.
  • 3. Obtain baseline 24-hour urine collection
  • for urea and creatinine clearance

4
Before peritoneal dialysis
  • 4. Explain to patient/parents/caregivers that
  • The prescription will be individualized.
  • Instilled volume almost increase over time.
  • Their total solute clearance will be monitored
  • IF RRF or peritoneal transport changes,
  • their prescription may need to change as
    well.

5
CAPD (1.5L or 2L) x qid CCPD 10 L last bag
(1L-2L) NIPD 10 L
First Prescription (Based on RRF, BSA)
1 month adjustment BSA, RRF, PET, S/S
CAPD(L, LA) CAPD(H, HA) WKt/Vlt1.7
WKt/Vlt2 WnCCrlt50 WnCCrlt60
CCPD WKt/Vlt2.1 WnCCrlt63
NIDP WKt/Vlt2.2 WnCCrlt66
???? ???? 1L-2L ?????
?????? 3??4? or 4??5?
??????? 1.5L?2L or 2L?2.5L
CCPD
HD
6
Initial prescription
  • (1) Full dose to meet minimal total solute
  • clearance goal
  • (2) Pt with a significant RRF, but Kt/V lt 2.0
    ?Incremental dosage of PD.
  • (3) Based on BSA and residual renal function
  • (4) During training, transporter type can be
    predicted from drain volume during a timed (4-
    hr) dwell with 2.5 glucose

7
Residual renal function
  • Renal GFR
  • 1/2 (renal CCr renal UreaCr)
  • BSA
  • 0.007184xBW(Kg)0.425xBH(cm)0.725

8
???????
  • CAPD ?????????3-4?
  • ????
  • CCPD ??last bag??9??,?CAPD??1-2?
  • ?????????4-6?
  • NIDP ?????????4-6?
  • ??dry

9
GFR gt2 ml/min
  • A. If patient's lifestyle choice is CAPD
  • BSAlt1.7 m2 ?4 x 1.5 L exchanges/day
  • BSA 1.7 to 2 m2 ?4 x 2.0 L exchanges/day
  • BSAgt2.0 m2 ? 4 x 2.5 L exchanges/day

10
GFR gt2 ml/min
  • B. If patient's lifestyle choice is CCPD
  • BSAlt1.7 m2
  • ?6 x 1.5 L (9hours/night) 1 L/d(last bag)
  • BSA 1.7 to 2.0 m2
  • ?4 x 2.0 L (9 hours/night)1.5-2.0 L/day (last
    bag)
  • BSAgt2.0 m2
  • ? 4 x 2.0 L (9 hours/night)2. L/day
    (last bag)

11
GFR gt2 ml/min
  • C. If patient's lifestyle choice is NIPD
  • Used at the initiation of dialysis.
  • Reserved for high or rapid transporters.
  • Patients with significant RRF (and ability to
    diuresis),
  • Nightly exchanges only (dry day)

12
2. GFR ?2 ml/min
  • A. If patient's lifestyle choice is CAPD
  • BSAlt1.7 m2 ? 4 x 2.0 L/day
  • BSA 1.7 to 2.0 m2 ? 4 x 2.5 L/day
  • BSA gt2.0 m2 ? 5 x 2.5 L/day
  • (Consider use of a simplified nocturnal
  • exchange device to achieve optimal dwell
    times and to augment clearance.)

13
2. GFR ?2 ml/min
  • B. If patient's lifestyle choice is CCPD
  • BSAlt1.7 m2
  • ?6 x 1.5 L (9hours/night) 1 L/d(last bag)
  • BSA 1.7 to 2.0 m2
  • ?4 x 2.0 L (9 hours/night)1.5-2.0 L/day(last
    bag)
  • BSAgt2.0 m2
  • ? 4 x 2.0 L (9 hours/night)2.0 L/day (last
    bag)
  • (???????1-2?)

14
CAPD (1.5L or 2L) x qid CCPD 10 L last bag
(1L-2L) NIPD 10 L
First Prescription (Based on RRF, BSA)
1 month adjustment BSA, RRF, PET, S/S
CAPD(L, LA) CAPD(H, HA) WKt/Vlt1.7
WKt/Vlt2 WnCCrlt50 WnCCrlt60
CCPD WKt/Vlt2.1 WnCCrlt63
NIDP WKt/Vlt2.2 WnCCrlt66
???? ???? 1L-2L ?????
?????? 3??4? or 4??5?
??????? 1.5L?2L or 2L?2.5L
CCPD
HD
15
CAPD (1.5L or 2L) x qid CCPD 10 L last bag
(1L-2L) NIPD 10 L
First Prescription (Based on RRF, BSA)
1 month adjustment BSA, RRF, PET, S/S
CAPD(L, LA) CAPD(H, HA) WKt/Vlt1.7
WKt/Vlt2 WnCCrlt50 WnCCrlt60
CCPD WKt/Vlt2.1 WnCCrlt63
NIDP WKt/Vlt2.2 WnCCrlt66
???? ???? 1L-2L ?????
?????? 3??4? or 4??5?
??????? 1.5L?2L or 2L?2.5L
CCPD
HD
16
Adequate dialysis
  • 1. Adequate solute removal ability
  • 2. Adequate ultrafiltration

17
1st month adjustment
  • Depend on
  • Peritoneal equilibration test (PET)
  • Residual renal function (RRF)
  • Body surface area (BSA)
  • S/S
  • weekly Kt/V and total nCCr
  • ?Adjustment of dialysis dose

18
Peritoneal Equilibration Test (PET)
  • ????Dialysate????,??8-12hrs
  • ?????,?PD Room???????
  • ???20?(lt25?)????????
  • ????10???2.5 Dialysate 2000ml?
  • ?2?? 400ml??,???????? ? ?dialysate?????????

19
Peritoneal Equilibration Test (PET)
  • Dialysate??????,?0?(0-dwell time)
    ????200ml???,?10ml ??,??????????????????
  • 120??,????????1/10 ?dialysate???????????,???????10
    ml???,?????????????
  • 120??????glucose, Cr ??
  • 240??,????dialysate????20? ????,??10ml
    dialysate???

20
Peritoneal equilibration test (PET)
  • Insertion 2 liters of 2.5 detrose dialysate
  • ? 0??, 2??, 4??
  • ? D/D0 glucose and D/P Cr?? ???
  • ? Low transporter
  • Low everage transporter
  • High average transporter
  • High transporter

21
(No Transcript)
22
(No Transcript)
23
(No Transcript)
24
  • Adequate
  • solute removal ability

25
CAPD (1.5L or 2L) x qid CCPD 10 L last bag
(1L-2L) NIPD 10 L
First Prescription (Based on RRF, BSA)
1 month adjustment BSA, RRF, PET, S/S
CAPD(L, LA) CAPD(H, HA) WKt/Vlt1.7
WKt/Vlt2 WnCCrlt50 WnCCrlt60
CCPD WKt/Vlt2.1 WnCCrlt63
NIPD WKt/Vlt2.2 WnCCrlt66
???? ???? 1L-2L ?????
?????? 3??4? or 4??5?
??????? 1.5L?2L or 2L?2.5L
CCPD
HD
26
???????
  • Weekly Kt/V
  • 7 x (peritoneal Kt/V renal Kt/V)
  • Weekly nCCr
  • 7 x (Peritoneal CCr renalGFR)/(BSA/1.73)
  • 7 x Peritoneal CCr
  • 1/2( renal CCrrenal
    ureCr)/(BSA/1.73)

27
Target of WKt/V, WnCcr
CAPD CAPD CCPD NIPD
L, LA H, HA CCPD NIPD
Weekly Kt/V gt1.7 gt2.0 gt2.1 gt2.2
Weekly nCCr gt50 L/week gt60 L/week gt63 L/week gt66 L/week
28
?????S/S
  • ????????
  • -Cr?, BUN ?or ?
  • -?? ???? ???
  • -???? ?? ?? ?? ??

29
Adjust dialysate
  • Kt/V and nCCr ?? or S/S
  • ? ?dialysate ?? or
  • ? ?????
  • ? ??????

30
  • CAPD (L/LA) 2L qid ?Kt/V lt 1.7 or nCCrlt50
  • ?2L change 5 ? ?2.5L change 5 ?
  • ? CCPD (????? ??10L)
  • ? HD
  • CAPD (H/HA) 2L qid ?Kt/V lt 2 or nCCrlt60
  • ?2L change 5 ? ?2.5L change 5 ?
  • ? APD (??10L)
  • ? CCPD (????? ??10L)? HD

31
  • APD 10 L (1.5)?Kt/V lt 2.2 or nCCrlt66
  • ?CCPD (?????????)
  • CCPD ?Kt/V lt 2.1 or nCCrlt63
  • ?H/D

32
CAPD (1.5L or 2L) x qid CCPD 10 L last bag
(1L-2L) NIPD 10 L
First Prescription (Based on RRF, BSA)
1 month adjustment BSA, RRF, PET, S/S
CAPD(L, LA) CAPD(H, HA) WKt/Vlt1.7
WKt/Vlt2 WnCCrlt50 WnCCrlt60
CCPD WKt/Vlt2.1 WnCCrlt63
NIPD WKt/Vlt2.2 WnCCrlt66
???? ???? 1L-2L ?????
?????? 3??4? or 4??5?
??????? 1.5L?2L or 2L?2.5L
CCPD
HD
33
?????S/S
  • ????????
  • -Cr?, BUN ?or ?
  • -?? ???? ???
  • -???? ?? ?? ?? ??

34
???????
  • ???? Hb, Ht, WBC, DC, Sugar, alb, A/G,
  • Alk-P, Chole, TG, BUN, Cr,
    Uric Acid,
  • Cr, K, NA, Ca, P,
  • ????? MCV, Ret, Iron, TIBC, Ferritin,
  • GOT, GPT,
  • ????? iPTH, Vit B12, Folic acid, nCCr, Kt/V
  • ???? PET, X-ray, HBsAg, Anti-HCV

35
Adequate ultrafiltration
36
??UFF ???
  • ????????2-3????? (4.25)????, ???????.
    ????????????.

37
???????
  • S/S
  • -??? ??
  • -?????????????

38
Management of Ultrafiltration inadequate
  • ??dialysate ?? or
  • ? ?????
  • ? ??????
  • ? ?Dextrous ??( 1.25?2.5?4.25)
  • ? Extraneal (Icodextrin)
  • ? ??????
  • ? urine lt500cc/day ?Transamin1Bid

39
CAPD (2L or 1.5L ) x qid CCPD 10 L last bag
(1L-2L) NIPD 10 L
First prescription
-??? ?? -?????????????
? ?dialysate ?? or ? ?????
? ?????? ? ?Dextrous ??(
1.25?2.5?4.25) ? Extraneal
(Icodextrin) ? ?????? ? urine
lt500cc/day ?Transamin1Bid
40
????
???? ?????
?????
??2??????
??
24H urine
?????
????
?????
??
????UF
RFF??
PET
??
??
??
1.?????? 2.????? 3.???? 4.????????
Type I UFF ??????
Type II UFF 1.?????? 2.??
41
Type I UFF
  • 70-80
  • Peritonitis ? ?transport effect
  • (D/PCr ?, D/D0 glucose?)
  • Reversible after 1 month

42
Type II UFF
  • ??
  • Sclerosing peritonitis and
  • peritoneal adhesion
  • ???????, ?????
  • ?????UFF ?inadequate solute transport

43
Type III UFF
  • High lymphatic absorption rate
  • Uncommon

44
Type IV UFF
  • Aquaporin deficiency
  • Rare
  • ?Water channels or ? ultra-small pore
  • ?deficient crystalloid-induced UF
  • Dx lt400ml UF with 4.25PET
  • lack of Na sieving early in the dwell
  • Tx colloid osmotic agents (icodextrin)

45
Type I UFF ????? ???????? ??? ?? lasix ??NPD ??HD or ??icodetran
Type II UFF ?????? ?? ??? ?? lasix ?tidal PD ?HD
?? ??? ????
?? ?? ???? ??PD
?????? ?????? ????
Type III UFF ?????? ???????
46
Icodextrin 7.5
  • Glucose polymer
  • MW16800
  • Osmolality 285mOsm/kg
  • UF occurred by colloid osmosis via small pores
  • No UF via ultra pores, through which glucose
    mainly acts, so no sodium sieving

47
?????????????
  • ??? ??????????
  • ???????????
  • ??????????
  • ?????????????
  • ???????????????
  • ?????????.

48
Pitfalls in Prescription of PD
  • Noncompliance
  • Patients on Standard CAPD are
  • (a) inappropriate dwell times
  • (b) failure to ? dialysis dose
  • to compensate for loss of RRF
  • (c) inappropriate instilled volume
  • (d) multiple rapid exchanges and 1 very long
    dwell
  • (e) inappropriate selection of dialysate
    glucose

49
Pitfalls in Prescription of PD
  • Patients on cycler therapy.
  • The drain time may be inappropriately long
  • (gt 20 min).
  • Inappropriately short dwell times
  • Failure to augment total dialysis dose
  • with a daytime dwell ("wet" day vs "dry"
    day)
  • could also result in underdialysis.
  • Inappropriate selection of dialysate glucose
  • ?may not allow maximization of UF,
  • resulting in less total clearance.
Write a Comment
User Comments (0)
About PowerShow.com